ask="2.55"
ask_size="1000"
average_daily_volume="57489"
bid="1.75"
bid_size="500"
book_value="2.84"
change="-0.05"
change_from_200_day_moving_average="-1.63"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-4.04"
change_From_52_week_low="0.35"
change_in_percent="-2.08%"
close="2.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-1.83"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="10701000"
high="2.45"
high_52_weeks="6.39"
last_trade_date="2/8/2017"
last_trade_price="2.35"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.30"
low_52_weeks="2.00"
market_capitalization="49.83M"
moving_average_200_day="3.98"
moving_average_50_day="2.53"
name="Strongbridge Biopharma plc"
notes="N/A"
one_year_target_price="14.33"
open="2.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-41.01%"
percent_change_from_50_day_moving_average="-6.98%"
percent_change_from_52_week_high="-63.22%"
percent_change_from_52_week_low="+17.50%"
previous_close="2.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.84"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.18"
stock_exchange="NMS"
symbol="SBBP"
volume="45420"
weeks_range_52="2.00 - 6.39"
